These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1085788)

  • 1. Ototoxicity of tobramycin: a clinical overview.
    Neu HC; Bendush CL
    J Infect Dis; 1976 Aug; 134 Suppl():S206-18. PubMed ID: 1085788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery from vestibular ototoxicity.
    Black FO; Gianna-Poulin C; Pesznecker SC
    Otol Neurotol; 2001 Sep; 22(5):662-71. PubMed ID: 11568676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of the ototoxicity of aminoglycosides. Comparison of tobramycin and gentamycin. Preliminary report].
    Fee WE
    Nouv Presse Med; 1978 Nov; 7(42):3854-5. PubMed ID: 309592
    [No Abstract]   [Full Text] [Related]  

  • 4. Ototoxicity of tobramycin in humans - influence of renal impairment.
    Brogard JM; Conraux C; Collard M; Lavillaureix J
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):408-16. PubMed ID: 6982875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoglycoside ototoxicity.
    Matz GJ
    Am J Otolaryngol; 1986; 7(2):117-9. PubMed ID: 3485932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of nephrotoxic and ototoxic effects of tobramycin in worldwide study.
    Bendush CL; Senior SL; Wooller HO
    Med J Aust; 1977 Oct; 2(3 Pt 2 Suppl):22-6. PubMed ID: 304521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical study on the ototoxic effects of tobramycin.
    Lehmann W; Häusler R; Waldvogel FA
    Arch Otorhinolaryngol; 1976 Jul; 212(3):203-11. PubMed ID: 1086087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ototoxicity in cystic fibrosis patients receiving intravenous tobramycin for acute pulmonary exacerbation: Ototoxicity following tobramycin treatment.
    Harruff EE; Kil J; Ortiz MGT; Dorgan D; Jain R; Poth EA; Fifer RC; Kim YJM; Shoup AG; Flume PA
    J Cyst Fibros; 2021 Mar; 20(2):288-294. PubMed ID: 33341407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monitoring drug ototoxicity with distortion products].
    Orts Alborch M; Morant Ventura A; García Callejo J; Ferrer Baixauli F; Martínez Beneito MP; Marco Algarra J
    Acta Otorrinolaringol Esp; 2000; 51(5):387-95. PubMed ID: 11000679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of aminoglycoside ototoxicity by high-frequency auditory evaluation: selected case studies.
    Fausti SA; Rappaport BZ; Schechter MA; Frey RH; Ward TT; Brummett RE
    Am J Otolaryngol; 1984; 5(3):177-82. PubMed ID: 6742338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ototoxicity of micronomicin sulfate--audiometric assessment].
    Hohzawa K; Shibuya M; Yuasa R
    Jpn J Antibiot; 1983 Oct; 36(10):2921-4. PubMed ID: 6674525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newborn hearing screening: tobramycin and vancomycin are not risk factors for hearing loss.
    de Hoog M; van Zanten BA; Hop WC; Overbosch E; Weisglas-Kuperus N; van den Anker JN
    J Pediatr; 2003 Jan; 142(1):41-6. PubMed ID: 12520253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced sudden hearing loss and vestibular disturbances.
    Federspil P
    Adv Otorhinolaryngol; 1981; 27():144-58. PubMed ID: 7034495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-frequency audiometric monitoring for early detection of aminoglycoside ototoxicity.
    Fausti SA; Henry JA; Schaffer HI; Olson DJ; Frey RH; McDonald WJ
    J Infect Dis; 1992 Jun; 165(6):1026-32. PubMed ID: 1583319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ototoxicity.
    Ballantyne J
    J Laryngol Otol Suppl; 1983; 8():9-12. PubMed ID: 6607302
    [No Abstract]   [Full Text] [Related]  

  • 16. Reversible tobramycin-induced bilateral high-frequency vestibular toxicity.
    Walsh RM; Bath AP; Bance ML
    ORL J Otorhinolaryngol Relat Spec; 2000; 62(3):156-9. PubMed ID: 10810261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vestibulo-toxicity of tobramycin.
    Baarsma EA; Rijntjes E
    J Laryngol Otol; 1979 Jul; 93(7):725-7. PubMed ID: 313972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ototoxicity in Nigeria: why it persists.
    Kokong DD; Bakari A; Ahmad BM
    Ear Nose Throat J; 2014 Jul; 93(7):256-64. PubMed ID: 25025411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of vestibular and auditory function in 76 patients treated with netilmicin.
    Tjernström O
    Scand J Infect Dis Suppl; 1980; Suppl 23():122-5. PubMed ID: 6970983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preliminary studies of the possible audio-toxicity of indomethacin].
    Crifò S; Orestano O; Sidoli A; D'Arco F
    Boll Soc Ital Biol Sper; 1974 Feb; 50(3):110-2. PubMed ID: 4547663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.